Pharmacogenetics of the ArylamineN-Acetyltransferases: A Symposium in Honor of Wendell W. Weber

Genetic Control of Isoniazid Metabolism in Man

David A. Evans, K. A. Manley, V.A. McKusick · BMJ · 1960 · 791 citations · Full text

Life Sciences, Genetics, Pharmacology +11

Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.

David W. Hein, Mark A. Doll, Adrian J. Fretland et al. · PubMed · 2000 · 687 citations

Medicine, Genetics, Molecular Genetics +17

A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-<i>b</i>]pyridine (PhIP)

Nobuyuki Ito, Ryohei Hasegawa, Masashi Sano et al. · Carcinogenesis · 1991 · 540 citations

Medicine, Oncology, Toxicology +9

Human Arylamine <i>N</i> -Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression

Martin Blum, Denis M. Grant, Wesley O. McBride et al. · DNA and Cell Biology · 1990 · 438 citations

Life Sciences, Genetics, Molecular Biology +11

Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.

Nicholas P. Lang, Marguerite A. Butler, Joyce Massengill et al. · PubMed · 1994 · 392 citations

Medicine, Pharmacology, Toxicology +17